Inhibition of the renin-angiotensin system

Is more better?

Sharon Anderson, Radko Komers

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Inhibitors of the renin-angiotensin-aldosterone system (RAS) exert beneficial effects in diabetic nephropathy, but the possibility of regression of existing renal lesions remains to be investigated. Teles et al. tested the effects of the RAS inhibitor losartan in rats starting 10 months after induction of diabetes, when glomerular lesions were already present. They linked the reductions of proteinuria with regression of mesangial expansion. More advanced lesions were not affected. There were no dose-response renal effects of losartan.

Original languageEnglish (US)
Pages (from-to)12-14
Number of pages3
JournalKidney International
Volume75
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Losartan
Renin-Angiotensin System
Kidney
Diabetic Nephropathies
Proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this

Inhibition of the renin-angiotensin system : Is more better? / Anderson, Sharon; Komers, Radko.

In: Kidney International, Vol. 75, No. 1, 01.2009, p. 12-14.

Research output: Contribution to journalArticle

@article{90a4875803514759936629b51a1724f4,
title = "Inhibition of the renin-angiotensin system: Is more better?",
abstract = "Inhibitors of the renin-angiotensin-aldosterone system (RAS) exert beneficial effects in diabetic nephropathy, but the possibility of regression of existing renal lesions remains to be investigated. Teles et al. tested the effects of the RAS inhibitor losartan in rats starting 10 months after induction of diabetes, when glomerular lesions were already present. They linked the reductions of proteinuria with regression of mesangial expansion. More advanced lesions were not affected. There were no dose-response renal effects of losartan.",
author = "Sharon Anderson and Radko Komers",
year = "2009",
month = "1",
doi = "10.1038/ki.2008.556",
language = "English (US)",
volume = "75",
pages = "12--14",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Inhibition of the renin-angiotensin system

T2 - Is more better?

AU - Anderson, Sharon

AU - Komers, Radko

PY - 2009/1

Y1 - 2009/1

N2 - Inhibitors of the renin-angiotensin-aldosterone system (RAS) exert beneficial effects in diabetic nephropathy, but the possibility of regression of existing renal lesions remains to be investigated. Teles et al. tested the effects of the RAS inhibitor losartan in rats starting 10 months after induction of diabetes, when glomerular lesions were already present. They linked the reductions of proteinuria with regression of mesangial expansion. More advanced lesions were not affected. There were no dose-response renal effects of losartan.

AB - Inhibitors of the renin-angiotensin-aldosterone system (RAS) exert beneficial effects in diabetic nephropathy, but the possibility of regression of existing renal lesions remains to be investigated. Teles et al. tested the effects of the RAS inhibitor losartan in rats starting 10 months after induction of diabetes, when glomerular lesions were already present. They linked the reductions of proteinuria with regression of mesangial expansion. More advanced lesions were not affected. There were no dose-response renal effects of losartan.

UR - http://www.scopus.com/inward/record.url?scp=58049197816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58049197816&partnerID=8YFLogxK

U2 - 10.1038/ki.2008.556

DO - 10.1038/ki.2008.556

M3 - Article

VL - 75

SP - 12

EP - 14

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -